Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-25-014420
Filing Date
2025-09-30
Accepted
2025-09-30 19:15:07
Documents
1
Period of Report
2025-09-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-70885.html 4  
1 PRIMARY DOCUMENT marketforms-70885.xml 4 9318
  Complete submission text file 0001214659-25-014420.txt   10849
Mailing Address 11411 SOUTHERN HIGHLANDS PARKWAY SUITE 190 LAS VEGAS NV 89141
Business Address
AULT MILTON C III (Reporting) CIK: 0001212502 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-40483 | Film No.: 251361990

Mailing Address 480 PEACHTREE ROAD NE, SECOND FLOOR SUITE 103 ATLANTA GA 30326
Business Address 480 PEACHTREE ROAD NE, SECOND FLOOR SUITE 103 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Issuer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)